These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4444089)

  • 1. Enhancement of neuraminidase activity with influenza virus by anti-influenza virus drug.
    Fukushima K; Toyoshima S
    Keio J Med; 1974 Sep; 23(3):125-36. PubMed ID: 4444089
    [No Abstract]   [Full Text] [Related]  

  • 2. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
    Shinkai K; Nishimura T
    J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
    [No Abstract]   [Full Text] [Related]  

  • 3. A QSAR study on influenza neuraminidase inhibitors.
    Verma RP; Hansch C
    Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors targeting the influenza virus hemagglutinin.
    Li F; Ma C; Wang J
    Curr Med Chem; 2015; 22(11):1361-82. PubMed ID: 25723505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of physicochemical factors on influenza virus neuraminidase].
    Nekliudova LI; Orlova NG; Makarova GI
    Vopr Virusol; 1973; 18(3):338-41. PubMed ID: 4769538
    [No Abstract]   [Full Text] [Related]  

  • 6. [A comparative study of the neuraminidase activity of 2 strains of influenza A2 type virus].
    Orlova NG; Mekhedov LN
    Vopr Virusol; 1970; 15(3):341-6. PubMed ID: 5472073
    [No Abstract]   [Full Text] [Related]  

  • 7. [Serological study of the neuraminidase activity of cholera filtrate and influenza virus].
    Gutman NR; Orlova NG
    Vopr Virusol; 1975; (1):34-9. PubMed ID: 1121851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple plaque assay for influenza A 2 viruses and its application to antiviral screening.
    Bentley J; Wickham EA
    Arch Gesamte Virusforsch; 1971; 33(3):234-41. PubMed ID: 5000191
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure and functions of influenza virus neuraminidase.
    Gong J; Xu W; Zhang J
    Curr Med Chem; 2007; 14(1):113-22. PubMed ID: 17266572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phospholipase C on influenza viruses: limited release of "soluble" V-antigens and of neuraminidase.
    Neurath AR; Rubin BA
    Life Sci; 1967 Mar; 6(6):575-80. PubMed ID: 4291878
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential effect of guanidine hydrochloride and heat on the haemagglutinin and neuraminidase of influenza viruses.
    David-West TS; Belyavin G
    Arch Gesamte Virusforsch; 1973; 43(4):367-76. PubMed ID: 4799156
    [No Abstract]   [Full Text] [Related]  

  • 12. Divalent oseltamivir analogues as potent influenza neuraminidase inhibitors.
    Yan ZL; Liu AY; Wei XX; Zhang Z; Qin L; Yu Q; Yu P; Lu K; Yang Y
    Carbohydr Res; 2019 May; 477():32-38. PubMed ID: 30954773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The behaviour of several influenza A2 virus strain neuraminidases after pronase treatment.
    Ionescu L; Handrache L; Alexandrescu M; Moroşanu V; Vancea G; Colev A
    Rev Roum Virol (1972); 1973; 10(3):209-12. PubMed ID: 4775622
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
    Cheng CK; Tsai CH; Shie JJ; Fang JM
    Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in anti-influenza agents with neuraminidase as target.
    Zhang J; Xu W
    Mini Rev Med Chem; 2006 Apr; 6(4):429-48. PubMed ID: 16613580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
    von Itzstein M; Dyason JC; Oliver SW; White HF; Wu WY; Kok GB; Pegg MS
    J Med Chem; 1996 Jan; 39(2):388-91. PubMed ID: 8558506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase activity of influenza virus-infected cells: localization and properties.
    Orlova TG; Orlova NG
    Acta Virol; 1975 Apr; 19(2):130-6. PubMed ID: 239558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 20. Amantadine-resistance as a genetic marker for influenza viruses.
    Appleyard G
    J Gen Virol; 1977 Aug; 36(2):249-55. PubMed ID: 561163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.